Adcock Ingram is a leading South African pharmaceutical manufacturer, listed on the Johannesburg Stock Exchange.
The Company manufactures, markets and distributes a wide range of healthcare products. The company is a leading supplier to both the private and public sectors of the market. Adcock Ingram is a level 3 B-BBEE contributor.
The Rest of Africa (RoA) offers business growth opportunities due to increasing GDP, a growing middle class, better education and the beginnings of a reduction in extreme poverty.
Adcock Ingram covers over 13 markets on the continent with a broad product range of OTC, Prescription, Hospital, and FMCG products. Our product offerings in the Rest of Africa follow largely what we have in South Africa. Adcock Ingram is making sure that we clearly understand the markets in which we operate and are aware of the risks and opportunities in each. We set out to attract the very best people who have a sound understanding of these markets and their consumers.
We have a state of the art manufacturing facility in Bangalore. Our Indian operation has given us the opportunity to strategically offer development and registration support to our other operations in Southern Africa and the Rest of Africa as well as augment our manufacturing capabilities.